Valted Seq
Gaithersburg, US · 1 known investors
Valted Seq develops an end-to-end platform powered by robotics and AI for single-cell analysis of brain tissue, enabling biomarker and therapeutic target discovery for neurodegenerative diseases. The company operates a large single-cell genomics database supporting research into conditions like Alzheimer's and Parkinson's disease.
AI & Machine LearningBiotechMedical Devices
Founders & leadership
DV
Dr. Valina DawsonCo-founder
DT
Dr. Ted DawsonExecutive Officer, Director
SS
Sheri Si-Yu FanExecutive Officer
MK
Michael KimExecutive Officer, Director
YH
Young Hoon KimExecutive Officer
SL
Seulki LeeExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$2.5MraisedFeb 2021 · 1 investors · OtherRule 506(b)
▶$2.5MraisedFeb 2021 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Sheri Si-Yu FanExecutive Officer
- Michael KimExecutive Officer, Director
- Ted DawsonExecutive Officer, Director
- Valina DawsonExecutive Officer, Director
- Young Hoon KimExecutive Officer
- Seulki LeeExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.